medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 606

<< Back Next >>

Rev Med Cos Cen 2013; 70 (606)

Síndrome de hellp

Núñez RD
Full text How to cite this article

Language: Spanish
References: 11
Page: 203-209
PDF size: 201.51 Kb.


Key words:

No keywords

ABSTRACT

HELLP syndrome represents a variety of severe preeclampsia constituted by hemolysis, elevated liver enzymes and thrombocytopenia that presents during the prepartum period or during the immediate puerperium as either a progressive or a sudden disease. As in preeclampsia its pathogenesis still remains unknown; however it is well known the need for aggressive management in a specialized delivery unit to avoid maternal and perinatal complications. Despite representing a true obstetric emergency there’s still unknown matters regarding HELLP´s syndrome diagnostic criteria and on corticosteroid use benefit as a therapeutic tool.


REFERENCES

  1. Alanis MC, Robinson CJ, Hulsey TC, Ebeling M, Jonson DD. Early-onset severe preeclampsia: induccion of labor vs elective caesarean delivery and neonatal outcomes. Am J Obstent Gynecol 2008; 199:262.e1-262.e6.

  2. Baxter K. Jason, Weinstein Luois, HELLP Syndrome: The State of the Art. Obstetrical and gynaecological survey 2004; 59(12) : 838-845

  3. Bombrys AE, Barton JR, Nowacki EA, et al. Ext management of severe preeclamsia at less than 27 weeks´ gestation: maternal and perinatal outcomes according to gestacional age by weeks at onset of expectant management. Am J Obstet Gynecol 2008; 199:247.e1-247.e6.

  4. Fonseca E Javier, Mendez Fabian, Cataño Claudia, Arias Fernando, Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: A double-blind paclebo-controlled, randomised clinical trial, American Journal os Obstetrics and Gynecology (2005) 193, 1591-8

  5. Habli M, Edtekhari N, Wiebracht E, et al. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am J Obstet Gynecol 2009;201:385.e1-5

  6. Joshi Deepak, James Andra, Quaglia Alberto, Westbrook H Rachel, Henegan A Michael, Liver disease in pregnancy, Lancet 2010;375:594-605

  7. Katz L, de Amorim MMR, Figueiroa JN, et al. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double- blind, placebo controlled, rondomized clinical trial. Am J Obstet Gynecol 2008;198:283.e1-283.e8.

  8. Martin Jr N. James, Rose H. Cristian, Understanting and managing HELLP syndrome: The integral role of aggressive glucocorticoids for mother and child, American Journal of Obstetrics and Gynecology (2006) 195.914-34

  9. O ´brien M. Jhon, Barton R Jhon, Controversias with the diagnosis and Management of HELLP síndrome, Clinical Obstetrics and Gynecology 2005, 48 (2):460-477

  10. Sep S, Verbeek J, Koek G, et al. Clinical differences between earlyonset HELLP syndrome and earlyonset preeclampsia during pregnancy and at least 6 months postpartum. Am J Obstet Gynecol 2010;202:271.e1-5.

  11. Stella L. Caroline, Malik M. Khurram, Sibai M. Baha. HELLP syndrome: an atypical presentation. Am J Obstet Gynecol 2008; May;198(5):e6-8




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2013;70